Mon, 10 Jun 2019 10:35:46 GMT
Roche's $4.3B Spark bid postponed again
The Swiss drugmaker Roche's takeover bid for Spark Therapeutics, the US gene therapy specialist, worth $4.3B has been delayed again, as the British and American regulators keep scrutinising the deal due to competition concerns.